Wyeth Wydase discontinued
Executive Summary
Wyeth has discontinued production of ocular surgery treatment Wydase (hyaluronidase). Wydase was manufactured at the company's Marietta, Penn. facility, which has been under an FDA consent decree since October 2000 (1"The Pink Sheet" Oct. 9, 2000, p. 3). Wyeth informed FDA of the discontinuation in the fourth quarter of 2000, but agreed to continue to manufacture the product until an alternate supplier of hyaluronidase was found...